Navigation Links
Maxam Nutraceutics Introduces PCA-Rx as a Natural Chelation Alternative for Autism Spectrum Disorder Treatment

HOOD RIVER, Ore., May 27 /PRNewswire/ -- According to the Center for Disease Control (CDC), autism has risen to an epidemic rate of 1 in 100 in the U.S., up from 1 in 150 in 2007. While controversy looms regarding its cause, many parents of autistic children believe a correlation exists with toxin accumulation. To give autism spectrum disorder (ASD) sufferers a natural alternative to chelation therapy, Maxam Nutraceutics ( has introduced PCA-Rx.

While chelation is commonly administered intravenously using the drug agents dimercaptosuccine acid (DMSA) and dimercaptopropane sulfonate (DMPS), this heavy metal removal method has come increasingly under fire by parents concerned about side effects.

Tina Beeck, who switched from chelation to PCA-Rx for treating her 4-year-old autistic son, Miller, stated, "We have been extremely pleased with PCA-Rx. We have seen tremendous cognitive gains – slowly at first and then dramatically. Sometimes he seems downright neuro-typical."

The result of years of rigorous research and development, PCA-Rx represents a breakthrough in toxin removal technology called Clathration Therapy. PCA-Rx is an epigenetic cell fermentation formula comprised of helpful bacteria and other microbes that, when used, become a natural, living part of the body's immune system. Administered orally, one to eight sprays per day under the tongue, it envelops, neutralizes and removes the harmful toxins through stool, urine, skin and breath, without ever touching vital organs or tissue.

PCA-Rx helps to eliminate heavy metals, chemical toxins and harmful parasite microorganisms; reduce cardio and cerebral vascular plaque; lower elevated enzyme counts; and decrease environmental illness effects.

"PCA-Rx represents the next generation of chelation technology," explained Maxam Nutraceutics President James Cole. "We're thrilled to provide autism sufferers a natural toxin removal treatment that's easy-to-use, powerful and with no known side effects."

PCA Rx is also used for Alzheimer's, candida, cervical dystonia, chemical exposure, heart disease, hepatitis, herpes, Lyme disease, paralysis, Niemann-Pick disease and uterine fibroids. It is available through

For more information, or interview scheduling with James Cole, contact Renee Cooper, ChristieCommunications( or (805)969-3744,

*PCA Rx has not been evaluated by the FDA and not intended to diagnose, treat, or cure any disease.

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Bioenergy Introduces Corvalen M(R) as a Natural Treatment Option for Fibromyalgia Symptoms
2. Bersin & Associates Introduces New Talent Management Framework
3. Varian Medical Systems Introduces ProBeam(TM) Proton Therapy Platform at Particle Therapy Co-operative Group (PT COG) 2010 Meeting
4. Ambry Genetics Introduces AmbryScreen(TM), a Genetic Test Screening for Some of the Most Common and Severe Genetic Disorders Affecting Newborns.
5. Ethicon Endo-Surgery Introduces Two New Staplers for Open Surgical Procedures at ASCRS
6. Biosense Webster Introduces the THERMOCOOL(R) SF Irrigated Catheter in the European Union
7. Ethicon Endo-Surgery Introduces HARMONIC FOCUS(R) Long Curved Shears for Deep Surgical Access
8. MAQUET Cardiovascular Introduces New VASOSHIELD Pressure Controlling Syringe to Help Preserve Graft Integrity for Coronary Artery Bypass Surgery Patients
9. Burton Medical Introduces the AIM-200(R) as a Versatile, Long-Lasting Light Source for Ambulatory Surgical Centers
10. Sikorsky Global Helicopters Introduces State-of-the-Art Emergency Medical Services Interior for S-76(R) Helicopter
11. Samplify Introduces New Compression Technology to Lower Costs for Mobile Operators Migrating to 4G
Post Your Comments:
(Date:11/26/2015)... Nederland, November 26, 2015 ... Een nieuwe aanpak combineert immunotherapie met Bremachlorin-photodynamische ... ) --> ...      (Photo: ) ... Universitair Medisch Centrum (LUMC) blijkt ...
(Date:11/26/2015)... Research and Markets ( ) has announced ... Outlook to 2019 - Rise in Cardiac Disorders and Growing ... to their offering. Boston ... scientific and others. --> The market ... Boston scientific and others. ...
(Date:11/26/2015)... Research and Markets ( ) ... Future Horizons and Growth Strategies in the Japanese ... Segment Forecasts, Competitive Intelligence, Emerging Opportunities" report ... --> This new 247-page report ... drug monitoring market, including emerging tests, technologies, instrumentation, ...
Breaking Medicine Technology:
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ProSidebar: ... in Final Cut Pro X. With ProSidebar: Fasion, video editors can easily add ... ProSidebar as a minimalist title opener. Utilize presets featuring self-animating drop zones, lines, ...
(Date:11/27/2015)... ... 27, 2015 , ... Consistent with the Radiology Business ... Better Radiology Marketing Programs meeting will showcase some of the best 2015 ... Caesars Palace in Las Vegas with a pre-conference session on a collaborative approach ...
(Date:11/27/2015)... ... November 27, 2015 , ... A simply groundbreaking television series, ... interesting show that delves into an array of issues that are presently affecting Americans. ... from open dialogue, this show is changing the subjects consumers focus on, one episode ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... an innovative online platform for mental health and wellness consultation, has collaborated with ... partnership will bridge the knowledge gap experienced by parents and bring advice from ...
(Date:11/27/2015)... ... 2015 , ... The men and women on this list ... the country. They have overseen financial turnarounds, shown commitment to their community through ... as a whole through their advocacy and professional efforts. , Becker's Hospital Review ...
Breaking Medicine News(10 mins):